KBIO INC.
๐บ๐ธUnited States
Clinical Trials
4
Active:0
Completed:4
Trial Phases
2 Phases
Early Phase 1:1
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)โข Click on a phase to view related trials
Phase 1
3 (75.0%)Early Phase 1
1 (25.0%)An Exploratory Study of ZB-06 as a Vaginal Contraceptive Film
- First Posted Date
- 2021-02-01
- Last Posted Date
- 2025-01-15
- Lead Sponsor
- KBio Inc
- Target Recruit Count
- 20
- Registration Number
- NCT04731818
- Locations
- ๐บ๐ธ
Eastern Virginia Medical School, Norfolk, Virginia, United States
KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers
Phase 1
Completed
- Conditions
- Covid19
- Interventions
- Biological: Low Dose of KBP-COVID-19Biological: PlaceboBiological: High Dose of KBP-COVID-19
- First Posted Date
- 2020-07-16
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- KBio Inc
- Target Recruit Count
- 102
- Registration Number
- NCT04473690
- Locations
- ๐บ๐ธ
Palm Beach Research Center, West Palm Beach, Florida, United States
๐บ๐ธVelocity Clinical Research, Meridian, Idaho, United States
๐บ๐ธPMG Research of Winston-Salem, Winston-Salem, North Carolina, United States
Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults
Phase 1
Completed
- Conditions
- Influenza
- First Posted Date
- 2020-06-19
- Last Posted Date
- 2021-09-16
- Lead Sponsor
- KBio Inc
- Target Recruit Count
- 120
- Registration Number
- NCT04439695
- Locations
- ๐บ๐ธ
Meridian Clinical Research, Omaha, Nebraska, United States
Safety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of HSV and HIV
- First Posted Date
- 2015-10-19
- Last Posted Date
- 2023-11-14
- Lead Sponsor
- KBio Inc
- Target Recruit Count
- 38
- Registration Number
- NCT02579083
- Locations
- ๐บ๐ธ
The Miriam Hospital, Providence, Rhode Island, United States
News
No news found